Immunization with a plasmid expressing pneumococcal surface protein A (PspA) can elicit protection against fatal infection with Streptococcus pneumoniae.

Abstract

Pneumococcal surface protein A (PspA) is a protectioneliciting protein of Streptococcus pneumoniae. We observed that immunization of BALB/c mice with a plasmid expressing PspA significantly protected the mice from lethal challenge with S. pneumoniae when compared to control mice that received injections of the plasmid vector alone. The plasmid construct expressing PspA has been designated pKSD2601. Mice immunized intramuscularly with pKSD2601 had a mean log of colony-forming units of 2.67 +/- 0.25 pneumococci circulating in their blood at 24 h after challenge as compared with control mice that had a mean log of colony-forming units of 4.95 +/- 0.59. Those mice with lower numbers of pneumococci subsequently survived the challenge. Given the quantitative nature and ultimate end point (ie live versus dead) our mouse model should be useful in working out optimum expression of bacterial genes for DNA immunization.

• Authors: L S McDaniel, F Loechel, C Benedict, T Greenway, D E Briles, R M Conry, D T Curiel
• Journal: Gene therapy (Gene Ther) Vol. 4 Issue 4 Pg. 375-7 (Apr 1997) ISSN: 0969-7128 [Print] England
• PMID: 9176525 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)

Chemical References

• Antigens, Surface
• Bacterial Proteins
• pneumococcal surface protein A

Topics

• Animals
• Antigens, Surface (genetics, metabolism)
• Bacterial Proteins (genetics, metabolism)
• Colony Count, Microbial
• Gene Transfer Techniques
• Genetic Therapy (methods)
• Immunization
• Injections, Intramuscular
• Mice
• Mice, Inbred BALB C
• Plasmids (metabolism)
• Pneumococcal Infections (microbiology, prevention & control)
• Polymerase Chain Reaction